News Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 01:30:00 2024-11-29 EST			5-day change	1st Jan Change
4,083.00 ^JPY	-0.49%		-0.73%	+0.72%

11-22	Hutchmed Announces Launch by Takeda of Fruzaqla (Fruquintinib) in Japan	CI
11-22	Hutchmed to get payment from Takeda as Fruzaqla launched in Japan	AN

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Hutchmed Announces Launch by Takeda of Fruzaqla (Fruquintinib) in Japan	11-22	CI
Hutchmed to get payment from Takeda as Fruzaqla launched in Japan	11-22	AN
Hutchmed to Receive Milestone Payment for Takeda's Fruzaqla Launch in Japan	11-22	MT
Integrated HIV, TB and Malaria Care Supports Mothers-to-Be and Newborns in Kenya	11-21	AQ
Alloy Therapeutics Signs Collaboration and License Agreement with Takeda Pharmaceutical Company Limited to Develop Cell Therapy Platform	11-20	CI
New Survey Data Highlights the Importance of Prioritizing Mental Health for Canadians Living with IBD	11-04	AQ
Takeda Pharmaceutical - Reports strong first half of fiscal year 2024 results and raises full-year outlook	11-01	AQ
Hutchmed China receives first milestone payment for Takeda drug sales	10-31	AN
Takeda Pharmaceutical : Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS) Form 6 K	10-31	PU
Takeda Pharmaceutical : FINANCIAL APPENDIX Form 6 K	10-31	PU
TAKEDA PHARMACEUTICAL : Form 6 K	10-31	PU
Takeda Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended September 30, 2024	10-31	CI
Takeda Pharmaceutical Company Limited, Q2 2025 Earnings Call, Oct 31, 2024	10-31
HUTCHMED Earns $20 Million Milestone Payment After Takeda Reaches Over $200 Million in Fruquintinib Sales	10-31	MT
Takeda Pharmaceutical Company Limited Declares Dividend for Second Quarter-End of Fiscal Year Ending March 31, 2025, Payable on December 2, 2024	10-31	CI
Takeda Pharmaceutical's Fiscal Q2 Core Earnings, Revenue Increase; Fiscal-Year Outlook Raised	10-31	MT
Takeda Pharmaceutical Posts Quarterly Net Profit, Raises Guidance -- Update	10-31	DJ
Takeda Pharmaceutical Posts Quarterly Net Profit, Raises Guidance	10-31	DJ
Japan's Takeda raises full-year profit forecast amid restructuring	10-31	RE
Takeda Pharmaceutical : Earnings Report（Kessan Tanshin）Download Earnings Report（Kessan Tanshin） (qr2024 q2 er en)	10-31	PU
Takeda Pharmaceutical : PresentationDownload Presentation (qr2024 q2 p01 en)	10-31	PU
Takeda Pharmaceutical : Quarterly Financial ReportDownload Quarterly Financial Report (qr2024 q2 qfr en)	10-31	PU
Takeda Pharmaceutical : Clinical Trials Summary (clinical trial summary october 2024)	10-31	PU
Takeda Pharmaceutical : 臨床試験サマリー（英語） (Clinical Trial Summary October 2024)	10-31	PU
Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook	10-31	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Pharmaceuticals

Filters